|
OMIM |
Link |
Information gain |
01 |
|
AD
|
[NCBI]
|
0.00179964
|
|
|
RA
|
[NCBI]
|
0.00177713
|
|
|
CFM1
|
[NCBI]
|
0.000732018
|
|
|
body mass index quantitative trait locus on chromosome 11
|
[NCBI]
|
0.000732018
|
|
|
body mass index quantitative trait locus on chromosome 6
|
[NCBI]
|
0.000732018
|
|
|
myasthenia, limb-girdle, with tubular aggregates
|
[NCBI]
|
0.000732018
|
|
|
speech-sound disorder
|
[NCBI]
|
0.00066762
|
|
|
stature quantitative trait locus 3
|
[NCBI]
|
0.00066762
|
|
|
stature as a quantitative trait
|
[NCBI]
|
0.000581979
|
|
|
BMND3
|
[NCBI]
|
0.000550555
|
|
|
APOE
|
[NCBI]
|
0.000503638
|
|
|
BULN1
|
[NCBI]
|
0.000479684
|
|
|
MDD
|
[NCBI]
|
0.000468948
|
|
|
pygmy
|
[NCBI]
|
0.000461132
|
|
|
twinning, dizygotic
|
[NCBI]
|
0.00040179
|
|
|
SLE
|
[NCBI]
|
0.000362023
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000292403
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.000287265
|
|
|
palatopharyngeal incompetence
|
[NCBI]
|
0.000281043
|
|
|
kabuki syndrome
|
[NCBI]
|
0.000258364
|
|
|
SHBG
|
[NCBI]
|
0.000252583
|
|
|
PPR
|
[NCBI]
|
0.000243309
|
|
|
KLK3
|
[NCBI]
|
0.000191759
|
|
|
PTH
|
[NCBI]
|
0.000179499
|
|
|
HFM
|
[NCBI]
|
0.000167287
|
|
|
APC
|
[NCBI]
|
0.000155158
|
|
|
CRC
|
[NCBI]
|
0.000122378
|
|
|
CF
|
[NCBI]
|
0.000120235
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
0.000113715
|
|
|
aromatic l-amino acid decarboxylase deficiency
|
[NCBI]
|
0.000112734
|
|
|
MAFD1
|
[NCBI]
|
0.000112584
|
|
|
VDR
|
[NCBI]
|
0.000112088
|
|
|
LKS
|
[NCBI]
|
0.000106715
|
|
|
OCP
|
[NCBI]
|
9.02591e-05
|
|
|
DFNA28
|
[NCBI]
|
8.97212e-05
|
|
|
myasthenia, limb-girdle, autoimmune
|
[NCBI]
|
8.97212e-05
|
|
|
HD
|
[NCBI]
|
8.33403e-05
|
|
|
FTD
|
[NCBI]
|
7.70067e-05
|
|
|
FA
|
[NCBI]
|
7.18042e-05
|
|
|
SRS
|
[NCBI]
|
6.38424e-05
|
|
|
PROP1
|
[NCBI]
|
5.36825e-05
|
|
|
FMF
|
[NCBI]
|
5.2327e-05
|
|
|
cataract, age-related nuclear
|
[NCBI]
|
5.19214e-05
|
|
|
RP
|
[NCBI]
|
5.18195e-05
|
|
|
ETM1
|
[NCBI]
|
5.149e-05
|
|
|
CPI
|
[NCBI]
|
4.60904e-05
|
|
|
ascaris lumbricoides infection, susceptibility to
|
[NCBI]
|
4.53423e-05
|
|
|
TS
|
[NCBI]
|
4.45823e-05
|
|
|
EGF
|
[NCBI]
|
4.42202e-05
|
|
|
porencephaly, familial
|
[NCBI]
|
4.05087e-05
|
|
|
BGLAP
|
[NCBI]
|
3.97153e-05
|
|
|
GRHL2
|
[NCBI]
|
3.6906e-05
|
|
|
PMF
|
[NCBI]
|
3.67033e-05
|
|
|
NGFB
|
[NCBI]
|
3.47487e-05
|
|
|
MBL2
|
[NCBI]
|
3.39918e-05
|
|
|
body mass index
|
[NCBI]
|
3.35772e-05
|
|
|
EGFR
|
[NCBI]
|
3.28706e-05
|
|
|
RNASE3
|
[NCBI]
|
3.09405e-05
|
|
|
myoclonic epilepsy, neonatal, with suppression-burst pattern
|
[NCBI]
|
3.09339e-05
|
|
|
MAOA
|
[NCBI]
|
2.94033e-05
|
|
|
TG
|
[NCBI]
|
2.80683e-05
|
|
|
sialuria
|
[NCBI]
|
2.66496e-05
|
|
|
alzheimer disease, susceptibility to, mitochondrial
|
[NCBI]
|
2.66496e-05
|
|
|
AMH
|
[NCBI]
|
2.6491e-05
|
|
|
CUL5
|
[NCBI]
|
2.55694e-05
|
|
|
kawasaki disease
|
[NCBI]
|
2.48714e-05
|
|
|
XYLT1
|
[NCBI]
|
2.35598e-05
|
|
|
MUC7
|
[NCBI]
|
2.35598e-05
|
|
|
GRB14
|
[NCBI]
|
2.20686e-05
|
|
|
GPD1
|
[NCBI]
|
2.20686e-05
|
|
|
CYP19A1
|
[NCBI]
|
2.14443e-05
|
|
|
ARPKD
|
[NCBI]
|
2.10489e-05
|
|
|
MGP
|
[NCBI]
|
2.08827e-05
|
|
|
CDAN1
|
[NCBI]
|
2.08827e-05
|
|
|
AGS1
|
[NCBI]
|
2.05194e-05
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
2.05194e-05
|
|
|
CEACAM5
|
[NCBI]
|
1.99225e-05
|
|
|
COMP
|
[NCBI]
|
1.94691e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
1.93157e-05
|
|
|
aging
|
[NCBI]
|
1.93157e-05
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
1.93157e-05
|
|
|
INHBB
|
[NCBI]
|
1.90577e-05
|
|
|
EDNRA
|
[NCBI]
|
1.83242e-05
|
|
|
MIRN16-1
|
[NCBI]
|
1.83242e-05
|
|
|
PWS
|
[NCBI]
|
1.82504e-05
|
|
|
TNFRSF13C
|
[NCBI]
|
1.76738e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.75217e-05
|
|
|
VRNI
|
[NCBI]
|
1.74808e-05
|
|
|
crigler-najjar syndrome
|
[NCBI]
|
1.71834e-05
|
|
|
alkaptonuria
|
[NCBI]
|
1.71834e-05
|
|
|
HTR1B
|
[NCBI]
|
1.70899e-05
|
|
|
CCL4
|
[NCBI]
|
1.70899e-05
|
|
|
NPPB
|
[NCBI]
|
1.70899e-05
|
|
|
COMT
|
[NCBI]
|
1.68812e-05
|
|
|
SOAT1
|
[NCBI]
|
1.65603e-05
|
|
|
ACE
|
[NCBI]
|
1.59567e-05
|
|
|
HGD
|
[NCBI]
|
1.56299e-05
|
|
|
pancreatic carcinoma
|
[NCBI]
|
1.5348e-05
|
|
|
MBP
|
[NCBI]
|
1.52885e-05
|
|
|
CCL3
|
[NCBI]
|
1.52166e-05
|
|
|
CCL18
|
[NCBI]
|
1.52166e-05
|
|
|
ESR1
|
[NCBI]
|
1.4637e-05
|
|
|
DA2A
|
[NCBI]
|
1.45217e-05
|
|
|
KTCN1
|
[NCBI]
|
1.45217e-05
|
|
|
CYP1A2
|
[NCBI]
|
1.44717e-05
|
|
|
PCD
|
[NCBI]
|
1.43287e-05
|
|
|
NCOA1
|
[NCBI]
|
1.38149e-05
|
|
|
IGFALS
|
[NCBI]
|
1.38048e-05
|
|
|
hypertension, essential
|
[NCBI]
|
1.37705e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
1.36835e-05
|
|
|
ADRB3
|
[NCBI]
|
1.35137e-05
|
|
|
IRDN
|
[NCBI]
|
1.35137e-05
|
|
|
ALB
|
[NCBI]
|
1.35112e-05
|
|
|
GAD2
|
[NCBI]
|
1.32281e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
1.30225e-05
|
|
|
SLC6A4
|
[NCBI]
|
1.27629e-05
|
|
|
DRD
|
[NCBI]
|
1.23402e-05
|
|
|
BIRC5
|
[NCBI]
|
1.22156e-05
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
1.20291e-05
|
|
|
CRP
|
[NCBI]
|
1.19896e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
1.19896e-05
|
|
|
PD
|
[NCBI]
|
1.17364e-05
|
|
|
LEP
|
[NCBI]
|
1.16946e-05
|
|
|
CRYAB
|
[NCBI]
|
1.15644e-05
|
|
|
FABP2
|
[NCBI]
|
1.11708e-05
|
|
|
thiourea tasting
|
[NCBI]
|
1.10912e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
1.06306e-05
|
|
|
ALMS
|
[NCBI]
|
1.05183e-05
|
|
|
DYX1
|
[NCBI]
|
1.05183e-05
|
|
|
IL5
|
[NCBI]
|
1.02994e-05
|
|
|
AFP
|
[NCBI]
|
1.00433e-05
|
|
|
CYP2A6
|
[NCBI]
|
9.98814e-06
|
|
|
ADRB2
|
[NCBI]
|
9.55429e-06
|
|
|
PRL
|
[NCBI]
|
9.48871e-06
|
|
|
CAT
|
[NCBI]
|
9.14726e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
9.14324e-06
|
|
|
apert syndrome
|
[NCBI]
|
8.97574e-06
|
|
|
EPO
|
[NCBI]
|
8.96955e-06
|
|
|
ADIPOQ
|
[NCBI]
|
8.90534e-06
|
|
|
FMR1
|
[NCBI]
|
8.54279e-06
|
|
|
TCF7L2
|
[NCBI]
|
8.44137e-06
|
|
|
HP
|
[NCBI]
|
8.33245e-06
|
|
|
phenylketonuria
|
[NCBI]
|
8.25754e-06
|
|
|
GTS
|
[NCBI]
|
8.11797e-06
|
|
|
AGT
|
[NCBI]
|
7.81965e-06
|
|
|
PROCR
|
[NCBI]
|
7.72351e-06
|
|
|
IGF1
|
[NCBI]
|
7.18498e-06
|
|
|
ASL
|
[NCBI]
|
7.18498e-06
|
|
|
MMP9
|
[NCBI]
|
7.18498e-06
|
|
|
HCH
|
[NCBI]
|
6.88055e-06
|
|
|
NF1
|
[NCBI]
|
6.79069e-06
|
|
|
GFAP
|
[NCBI]
|
6.72281e-06
|
|
|
PCTT
|
[NCBI]
|
6.51993e-06
|
|
|
DRD4
|
[NCBI]
|
6.26894e-06
|
|
|
MC4R
|
[NCBI]
|
6.26894e-06
|
|
|
SMA3
|
[NCBI]
|
6.17615e-06
|
|
|
malaria, susceptibility to
|
[NCBI]
|
6.17615e-06
|
|
|
MTTL1
|
[NCBI]
|
5.81197e-06
|
|
|
CCL22
|
[NCBI]
|
5.81197e-06
|
|
|
GLC1A
|
[NCBI]
|
5.53547e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
5.45171e-06
|
|
|
MPO
|
[NCBI]
|
5.38818e-06
|
|
|
LPL
|
[NCBI]
|
5.33242e-06
|
|
|
PCNA
|
[NCBI]
|
5.33034e-06
|
|
|
HLA-A
|
[NCBI]
|
5.18237e-06
|
|
|
SMN1
|
[NCBI]
|
5.0778e-06
|
|
|
MEN1
|
[NCBI]
|
4.97596e-06
|
|
|
GCK
|
[NCBI]
|
4.97596e-06
|
|
|
POAG
|
[NCBI]
|
4.95187e-06
|
|
|
BDNF
|
[NCBI]
|
4.84545e-06
|
|
|
PJS
|
[NCBI]
|
4.66774e-06
|
|
|
GH1
|
[NCBI]
|
4.63939e-06
|
|
|
DHFR
|
[NCBI]
|
4.56441e-06
|
|
|
AVP
|
[NCBI]
|
4.50413e-06
|
|
|
TPO
|
[NCBI]
|
4.42888e-06
|
|
|
HSAN3
|
[NCBI]
|
4.41973e-06
|
|
|
VMD
|
[NCBI]
|
4.17141e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
4.07413e-06
|
|
|
MS
|
[NCBI]
|
3.73388e-06
|
|
|
ALGS1
|
[NCBI]
|
3.70757e-06
|
|
|
G6PD
|
[NCBI]
|
3.6257e-06
|
|
|
MG
|
[NCBI]
|
3.57684e-06
|
|
|
CHS
|
[NCBI]
|
3.46535e-06
|
|
|
SLPI
|
[NCBI]
|
3.37616e-06
|
|
|
CNTF
|
[NCBI]
|
3.32485e-06
|
|
|
CFTR
|
[NCBI]
|
3.30179e-06
|
|
|
RHO
|
[NCBI]
|
3.16077e-06
|
|
|
PON1
|
[NCBI]
|
2.98765e-06
|
|
|
obesity
|
[NCBI]
|
2.89805e-06
|
|
|
sickle cell anemia
|
[NCBI]
|
2.89805e-06
|
|
|
CD
|
[NCBI]
|
2.77579e-06
|
|
|
HHF2
|
[NCBI]
|
2.71791e-06
|
|
|
CASR
|
[NCBI]
|
2.62023e-06
|
|
|
ABP1
|
[NCBI]
|
2.47677e-06
|
|
|
NPPA
|
[NCBI]
|
2.41138e-06
|
|
|
ABCG2
|
[NCBI]
|
2.27558e-06
|
|
|
HEMB
|
[NCBI]
|
2.10965e-06
|
|
|
HGF
|
[NCBI]
|
2.07755e-06
|
|
|
PMD
|
[NCBI]
|
2.06822e-06
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.88124e-06
|
|
|
APOB
|
[NCBI]
|
1.87279e-06
|
|
|
LQT1
|
[NCBI]
|
1.66932e-06
|
|
|
F3
|
[NCBI]
|
1.53828e-06
|
|
|
EIG
|
[NCBI]
|
1.38624e-06
|
|
|
TLR2
|
[NCBI]
|
1.37327e-06
|
|
|
VEGF
|
[NCBI]
|
1.23124e-06
|
|
|
NIDDM
|
[NCBI]
|
1.21404e-06
|
|
|
LAM
|
[NCBI]
|
1.20706e-06
|
|
|
AKR1B1
|
[NCBI]
|
1.09367e-06
|
|
|
SERPINA6
|
[NCBI]
|
9.82165e-07
|
|
|
FGFR3
|
[NCBI]
|
9.50441e-07
|
|
|
IAPP
|
[NCBI]
|
8.50132e-07
|
|
|
TTR
|
[NCBI]
|
6.44323e-07
|
|
|
AVSD
|
[NCBI]
|
6.22198e-07
|
|
|
asthma, susceptibility to
|
[NCBI]
|
6.22198e-07
|
|
|
ACHE
|
[NCBI]
|
6.08995e-07
|
|
|
ACH
|
[NCBI]
|
5.8958e-07
|
|
|
temporal arteritis
|
[NCBI]
|
5.43589e-07
|
|
|
TH
|
[NCBI]
|
4.58799e-07
|
|
|
XDH
|
[NCBI]
|
4.57053e-07
|
|
|
alopecia, androgenetic
|
[NCBI]
|
4.37456e-07
|
|
|
SLC6A3
|
[NCBI]
|
3.59503e-07
|
|
|
CRH
|
[NCBI]
|
2.67264e-07
|
|
|
AHO
|
[NCBI]
|
2.47153e-07
|
|
|
amyloidosis vi
|
[NCBI]
|
2.05719e-07
|
|
|
CHAT
|
[NCBI]
|
1.90632e-07
|
|
|
ADHD
|
[NCBI]
|
1.45467e-07
|
|
|
GNRH1
|
[NCBI]
|
1.42641e-07
|
|
|
WBS
|
[NCBI]
|
1.17719e-07
|
|
|
BLM
|
[NCBI]
|
1.14742e-07
|
|
|
LS
|
[NCBI]
|
1.14742e-07
|
|
|
HBB
|
[NCBI]
|
9.9167e-08
|
|
|
SOD2
|
[NCBI]
|
8.88157e-08
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
7.61798e-08
|
|
|
MUC1
|
[NCBI]
|
6.44236e-08
|
|
|
krabbe disease
|
[NCBI]
|
6.03834e-08
|
|
|
BWS
|
[NCBI]
|
4.18672e-08
|
|
|
TLR4
|
[NCBI]
|
3.22646e-08
|
|
|
WHS
|
[NCBI]
|
3.11407e-08
|
|
|
AR
|
[NCBI]
|
3.04008e-08
|
|
|
TNF
|
[NCBI]
|
1.08306e-08
|
|
|
PF4
|
[NCBI]
|
7.21495e-09
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
1.40465e-09
|
|
|
ADA
|
[NCBI]
|
3.20422e-10
|
|